News | April 20, 2026
Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The investment case for health technology in India is frequently overstated in one direction and understated in another
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Former Wavemaker executive to lead media strategy and digital transformation agenda
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
